RUNX1 and acute myeloid leukemia: Furthermore, we compared the clinicopathological characteristics with FAM-predicted risk factors and found that the poor prognosis factors, such as runx1 mutation and old age, are highly enriched in the high-risk (HR) cohort (Figures 3A, B), confirming that FAM indeed plays a role in AML progression.